Myeloid ectopic viral integration site 2 accelerates the progression of Alzheimer's disease
Aging Cell · 2024
DOI: 10.1111/acel.14260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2024. Verfasst von Yuting Cui und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory of Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid Precursor Protein Secretases, Aspartic Acid Endopeptidases, Homeodomain Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Hospital Authority Youth Program, HUIZHI Talent Leadership Development Program of Xuanwu Hospital, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Amyloid plaques, a major pathological hallmark of Alzheimer's disease (AD), are caused by an imbalance between the amyloidogenic and non‐amyloidogenic pathways of amyloid precursor protein (APP). BACE1 cleavage of APP is the rate‐limiting step for amyloid‐β production and plaque formation in AD. Although the alteration of BACE1 expression in AD has been investigated, the underlying mechanisms remain unknown. In this study, we determined MEIS2 was notably elevated in AD models and AD patients. Alterations in the expression of MEIS2 can modulate the levels of BACE1. MEIS2 downregulation improved the learning and memory retention of AD mice and decreased the number of amyloid plaques. MEIS2 binds to the BACE1 promoter, positively regulates BACE1 expression, and accelerates APP amyloid degradation in vitro. Therefore, our findings suggest that MEIS2 might be a critical transcription factor in AD, since it regulates BACE1 expression and accelerates BACE1‐mediated APP amyloidogenic cleavage. MEIS2 is a promising early intervention target for AD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory of Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China.
- Department of Clinical Laboratory, Beijing Huairou Hospital, Beijing, People's Republic of China.
ORCID-Profile: Peichang Wang, Yaqi Wang
Förderung
- Beijing Hospital Authority Youth Program
- HUIZHI Talent Leadership Development Program of Xuanwu Hospital
- National Natural Science Foundation of China
- Grants from the State Key Program of the National Natural Science Foundation of China
- Beijing Key Clinical Specialty
- Beijing Sail Plan for Talents Development
Zitieren
APA
Cui, Y., Zhang, X., Liu, J., Hou, Y., Song, Q., Cao, M., Zhang, J., Wang, X., Liu, C., Wang, P., & Wang, Y. (2024). Myeloid ectopic viral integration site 2 accelerates the progression of Alzheimer's disease. Aging Cell. https://doi.org/10.1111/acel.14260
Vancouver
Cui Y, Zhang X, Liu J, Hou Y, Song Q, Cao M, et al. Myeloid ectopic viral integration site 2 accelerates the progression of Alzheimer's disease. Aging Cell. 2024. doi:10.1111/acel.14260
BibTeX
@article{Cui2024,
author = {Cui, Yuting and Zhang, Xiaomin and Liu, Jing and Hou, Yuli and Song, Qiao and Cao, Min and Zhang, Jingjing and Wang, Xiaoling and Liu, Congcong and Wang, Peichang and Wang, Yaqi},
title = {Myeloid ectopic viral integration site 2 accelerates the progression of Alzheimer's disease},
journal = {Aging Cell},
year = {2024},
doi = {10.1111/acel.14260}
}
EUVIMED